One of the leading firms in drug safety software, Relsys, has a new VP of global sales. John Loucks who joins the firm after 12 years with the SAS in various positions, most recently as the national sales director for the life sciences division as the company’s Vice President of Global Sales. “With his excellent track record and deep understanding of [the] pharmaceutical industry’s needs, he will serve our clients well,” said Dave Bajaj, president and CEO of Relsys. “John brings to Relsys deep expertise in developing and selling complex solutions to meet the needs of the life sciences industry.”